Loading...
Pancreatic Ductal Adenocarcinoma: Current and Evolving Therapies
Pancreatic ductal adenocarcinoma (PDAC), which constitutes 90% of pancreatic cancers, is the fourth leading cause of cancer-related deaths in the world. Due to the broad heterogeneity of genetic mutations and dense stromal environment, PDAC belongs to one of the most chemoresistant cancers. Most of...
Na minha lista:
| Udgivet i: | Int J Mol Sci |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
MDPI
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5535831/ https://ncbi.nlm.nih.gov/pubmed/28640192 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms18071338 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|